MIGUEL ANGEL
SANZ ALONSO
CATEDRÁTICO/A DE UNIVERSIDAD
Hospital Universitario de Jaén
Jaén, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Jaén (4)
2022
2021
-
Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens
Scientific Reports, Vol. 11, Núm. 1
2019
-
A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients
Leukemia Research, Vol. 76, pp. 1-10
2014
-
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry: A bridge to individualized medicine
Clinical Lymphoma, Myeloma and Leukemia, Vol. 14, Núm. 4, pp. 305-318